beta

IMDZ

Immune Design Corp.

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Immune Design Corp is a clinical-stage immunotherapy company with next-generation in vivo approaches designed to enable the body's immune system to fight disease.

Market Cap: 180 Million

Primary Exchange: NASDAQ Global Market

Website: http://www.immunedesign.com

Shares Outstanding: 48.1 Million

Float: 47.6 Million

Dividend: 0.0 (0.0%)

Beta: 2.101459

Sector: Healthcare

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1079 trading days

From: 2014-12-22 To: 2019-04-01

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud